Adjuvant Toripalimab Better Tolerated Than HDI in Mucosal Melanoma
Toripalimab is similarly effective but safer than high-dose interferon-α2b for patients with resected mucosal melanoma, a new study suggests.
Melanoma
AI and Dermatologists Similarly Judge Melanoma Thickness
Readers most accurately discriminated between thin (≤1.0 mm) and thick melanomas (>1.0 mm).
Medically Integrated Dispensing on the Rise in US Oncology Practices
From 2010 to 2019, the percentage of oncology practices with medically integrated dispensing more than doubled.
Neural Network-Based Model Shows Potential to Decrease SLN Biopsy Rate, Costs in Melanoma Subtypes
A decision-analytic study sought to identify an effective model for predicting risk for SLN biopsy and metastasis in patients with cutaneous melanoma.
Factors ID’d for Self-Exam Compliance Among Melanoma Patients
Younger age, female sex, increased disease severity, and having a significant other to help with exams may improve compliance.
Incidence of Melanoma Diagnosis, Biopsy Parallel Skin Screening Uptake
Researchers sought to determine if the incidence of melanoma diagnoses and biopsies increased with a greater uptake of skin screenings.
Risk of Cancer-Specific Death May Remain Elevated for 30 Years
Patients with certain cancers have an increased risk of cancer-specific mortality that persists for 30 to 35 years after diagnosis.
Primary Care-Based Screening Ups Thin Melanoma Detection
Incidence of melanoma thicker than 4 mm did not differ significantly for screened and unscreened patients.
Global Burden of Melanoma Considerable, Set to Rise by 2040
If 2020 rates continue, burden estimated to increase by about 50 percent for incidence, 68 percent for deaths by 2040
Does Aspirin Reduce the Risk of Invasive Melanoma in Older Adults?
Results from a randomized trial neither support nor rule out the possibility that aspirin might have a chemopreventive effect on melanoma incidence.
- Loading...
Loading...
Next post in Melanoma
Loading... 
Loading...